Gene · 6311
Papers3,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,217
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The GGC repeat expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy type 3. | Brain | 2021 | 33693509 | PubTator, text mining | PubMed |
| Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation. | Elife | 2021 | 33689682 | PubTator, text mining | PubMed |
| Redox Imbalance Associates with Clinical Worsening in Spinocerebellar Ataxia Type 2. | Oxid Med Cell Longev | 2021 | 33688396 | PubTator, text mining | PubMed |
| Clinical and genomic analysis of a large Chinese family with familial cortical myoclonic tremor with epilepsy and SAMD12 intronic repeat expansion. | Epilepsia Open | 2021 | 33681653 | PubTator, text mining | PubMed |
| Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease. | Nat Commun | 2021 | 33674575 | PubTator, text mining | PubMed |
| Genetic rhabdomyolysis within the spectrum of the Spinocerebellar Ataxia type 2 responsive to pregabalin. | Cerebellum Ataxias | 2021 | 33673860 | PubTator, text mining | PubMed |
| Rare Recurrent Variants in Noncoding Regions Impact Attention-Deficit Hyperactivity Disorder (ADHD) Gene Networks in Children of both African American and European American Ancestry. | Genes (Basel) | 2021 | 33671795 | PubTator, text mining | PubMed |
| Zebrafish Models of Autosomal Dominant Ataxias. | Cells | 2021 | 33671313 | PubTator, text mining | PubMed |
| Expression Profiling Identifies TWIST2 Target Genes in Setleis Syndrome Patient Fibroblast and Lymphoblast Cells. | Int J Environ Res Public Health | 2021 | 33669496 | PubTator, text mining | PubMed |
| Application of a Clinical Workflow May Lead to Increased Diagnostic Precision in Hereditary Spastic Paraplegias and Cerebellar Ataxias: A Single Center Experience. | Brain Sci | 2021 | 33669240 | PubTator, text mining | PubMed |
| Deletion of conserved non-coding sequences downstream from NKX2-1: A novel disease-causing mechanism for benign hereditary chorea. | Mol Genet Genomic Med | 2021 | 33666368 | PubTator, text mining | PubMed |
| Evidence of synergism among three genetic variants in a patient with LMNA-related lipodystrophy and amyotrophic lateral sclerosis leading to a remarkable nuclear phenotype. | Mol Cell Biochem | 2021 | 33661429 | PubTator, text mining | PubMed |
| LINC00941 promotes proliferation and metastasis of pancreatic adenocarcinoma by competitively binding miR-873-3p and thus upregulates ATXN2. | Eur Rev Med Pharmacol Sci | 2021 | 33660796 | PubTator, text mining | PubMed |
| Descriptive epidemiological study on patients with movement disorders, with emphasis on Parkinson's disease. | Sao Paulo Med J | 2021 | 33656125 | PubTator, text mining | PubMed |
| Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung Cancer. | Adv Sci (Weinh) | 2021 | 33643802 | PubTator, text mining | PubMed |
| Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases. | Front Neurosci | 2021 | 33642983 | PubTator, text mining | PubMed |
| Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia. | Neurobiol Dis | 2021 | 33636389 | PubTator, text mining | PubMed |
| Phenotypic and molecular diversities of spinocerebellar ataxia type 2 in Japan. | J Neurol | 2021 | 33625581 | PubTator, text mining | PubMed |
| Rapid Molecular Screen of Spinocerebellar Ataxia Types 1, 2, and 3 by Triplet-Primed PCR and Melting Curve Analysis. | J Mol Diagn | 2021 | 33618058 | PubTator, text mining | PubMed |
| Genetics and the Individualized Therapy of Vestibular Disorders. | Front Neurol | 2021 | 33613440 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6311/papers?page=51